A molecular analysis of the gene in Caucasian South Africans with Parkinson's disease.
Volume: 5
Issue: 2
Year of Publication:
Abstract summary
The molecular basis of Parkinson's disease in South African population groups remains elusive. To date, substitutions in the gene are the most common large-effect genetic risk factor for Parkinson's disease. The primary objective of this study was to determine the prevalence of substitutions in South Africans with idiopathic Parkinson's disease.Participants were recruited from tertiary hospitals in the Gauteng Province in South Africa. All participants were screened for substitutions in exon 8-11 and the full coding region was analysed in 20 participants. Peripheral -glucocerebrosidase enzymatic activity of -carriers was measured in mixed leukocytes.Of 105 Caucasian Parkinson's disease participants (82.7% Afrikaner) with an average age of disease onset of 61.9 ± 12.2 years and 40 controls (age 73.4 ± 12.4 years) were included. Heterozygous substitutions were identified in 12.38% of affected participants (p.G35A, p.E326K, p.I368T, p.T369M, p.N370S, p.P387L and p.K441N) and 5.00% of controls (p.E326K and p.T369M). The substitutions ranged from predicted benign to moderately damaging; with p.E326K and p.T369M most prevalent, followed by the Afrikaner Gaucher disease substitution p.P387L. Severe Gaucher disease mutations, like p.L444P, were absent in this cohort. Enzyme activity analysis revealed a nonsignificant reduction in the -Parkinson's disease individuals (14.49 ± 2.30 nmol/h/mg protein vs. 15.98 ± 3.06 nmol/h/mg in control samples). substitutions occur in both young-onset and late-onset Parkinson's cases in the cohort.Mild substitutions that may not cause Gaucher disease were a common risk factor for Parkinson's disease in the participant group.Study Outcome
Source Link: Visit source
Statistics
Citations : Alcalay, R. , Caccappolo E., Mejia‐Santana H., Tang M.‐X., Rosado L., Reilly M. O., et al. 2012. Cognitive performance of GBA mutation carriers with early‐onset PD the CORE‐PD study. Neurology 78:1434–1440.Authors : 4
Identifiers
Doi : 10.1002/mgg3.267SSN : 2324-9269